EKSO BIONICS HOLDINGS, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for EKSO BIONICS HOLDINGS, INC. (CHRN), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud · Insider-trading data from SEC EDGAR
Latest filing:
Compiled automatically from SEC EDGAR Form 4 filings and refreshed daily. Figures count purchases (code P) and sales (code S) only — not grants, option exercises, or gifts. How this page is built. Not investment advice.
Quick Answer
Are CHRN insiders buying or selling?
In the last 12 months, EKSO BIONICS HOLDINGS, INC. insiders reported 5 open-market purchases ($1.2M) and 6 sales ($232.1K) — net buying of $971.7K. Since May 2018, Trabud has recorded 40 Form 4 filings for CHRN: 7 buys ($1.5M) and 33 sells ($615.1K).
Source: SEC EDGAR Form 4
What stands out
- The largest open-market purchase in the last 12 months was $970.1K by ASHER DANIEL (10% Owner) on Feb 17, 2026. SEC ↗
- The most recent open-market purchase was reported on Mar 20, 2026 (6 months ago).
Key Statistics (May 2018 – Mar 20, 2026)
Total Form 4 filings
40
SEC EDGAR
Insider filers
8
Insider buys (7)
$1.5M
Insider sells (33)
$615.1K
Insider sentiment
Net buyingNet insider flow of $905.7K in net buying since May 2018, and $971.7K in net buying over the last 12 months.
Recent CHRN insider transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Mar 20, 2026 | Jason C Jones | Chief Operating Officer | Purchase | 1.3K | $11.85 | $15.5K | SEC ↗ |
| Mar 20, 2026 | Jerome Wong | Chief Financial Officer | Purchase | 1.3K | $11.85 | $15.5K | SEC ↗ |
| Feb 20, 2026 | ASHER DANIEL | 10% Owner | Purchase | 15.5K | $12.30 | $191.2K | SEC ↗ |
| Feb 19, 2026 | ASHER DANIEL | 10% Owner | Purchase | 1.2K | $9.60 | $11.5K | SEC ↗ |
| Feb 17, 2026 | ASHER DANIEL | 10% Owner | Purchase | 102.0K | $9.51 | $970.1K | SEC ↗ |
| Jan 7, 2026 | Jason C Jones | Chief Operating Officer | Sale | 1.3K | $9.25 | $12.2K | SEC ↗ |
| Dec 10, 2025 | Jason C Jones | Chief Operating Officer | Sale | 270 | $4.70 | $1.3K | SEC ↗ |
| Dec 10, 2025 | Jerome Wong | Chief Financial Officer | Sale | 1.2K | $4.70 | $5.8K | SEC ↗ |
| Nov 12, 2025 | Jerome Wong | Chief Financial Officer | Sale | 11.3K | $4.80 | $54.2K | SEC ↗ |
| Nov 12, 2025 | Jason C Jones | Chief Operating Officer | Sale | 9.7K | $4.80 | $46.7K | SEC ↗ |
| Nov 12, 2025 | Scott G. Davis | CEO | Sale | 23.3K | $4.80 | $111.9K | SEC ↗ |
| Mar 14, 2024 | Corinna Lathan | Director | Purchase | 13.7K | $1.13 | $15.5K | SEC ↗ |
| Aug 19, 2023 | Scott G. Davis | President & COO | Sale | 37.4K | $1.00 | $37.3K | SEC ↗ |
| Aug 19, 2023 | Jerome Wong | Chief Financial Officer | Sale | 12.8K | $1.00 | $12.7K | SEC ↗ |
| May 26, 2023 | SHERMAN STEVEN | Executive Chair | Sale | 45.7K | $1.44 | $65.9K | SEC ↗ |
| May 17, 2023 | Jason C Jones | Chief Operating Officer | Sale | 3.4K | $1.57 | $5.4K | SEC ↗ |
| Dec 8, 2022 | SHERMAN STEVEN | Executive Chair | Sale | 10.6K | $1.28 | $13.5K | SEC ↗ |
| Nov 23, 2022 | SHERMAN STEVEN | CEO & Chairman | Sale | 5.8K | $1.26 | $7.3K | SEC ↗ |
| Nov 17, 2022 | Jason C Jones | Senior VP Product Development | Sale | 782 | $1.28 | $1.0K | SEC ↗ |
| Nov 17, 2022 | Jerome Wong | Chief Financial Officer | Sale | 723 | $1.28 | $927.25 | SEC ↗ |
| Oct 26, 2022 | SHERMAN STEVEN | CEO & Chairman | Sale | 5.9K | $1.29 | $7.6K | SEC ↗ |
| Sep 26, 2022 | SHERMAN STEVEN | CEO & Chairman | Sale | 6.0K | $1.75 | $10.6K | SEC ↗ |
| Sep 2, 2022 | Jason C Jones | Senior VP Product Development | Sale | 5.9K | $2.31 | $13.6K | SEC ↗ |
| Aug 23, 2022 | SHERMAN STEVEN | CEO & Chairman | Sale | 5.6K | $2.20 | $12.3K | SEC ↗ |
| Aug 4, 2022 | Jerome Wong | InterimChief Financial Officer | Sale | 1.7K | $1.80 | $3.0K | SEC ↗ |
Showing the 25 most recent of 40 Form 4 filings for EKSO BIONICS HOLDINGS, INC..
Most active CHRN insiders
- SHERMAN STEVEN14 filings
- Jason C Jones9 filings
- Jerome Wong7 filings
- ASHER DANIEL3 filings
- Scott G. Davis3 filings
Ask anything about CHRN insider activity
Use Trabud's AI agent to query EKSO BIONICS HOLDINGS, INC.'s Form 4 history in plain English — "Show me CHRN CEO purchases this year" or compare it against any other ticker.
Open the AI agentCHRN insider trading FAQ
Are EKSO BIONICS HOLDINGS, INC. insiders buying or selling?
In the last 12 months, EKSO BIONICS HOLDINGS, INC. insiders reported 5 open-market purchases ($1.2M) and 6 sales ($232.1K) — net buying of $971.7K. Since May 2018, Trabud has recorded 40 Form 4 filings for CHRN: 7 buys ($1.5M) and 33 sells ($615.1K). Over the full record that is net buying of $905.7K.
How many insiders trade CHRN stock?
8 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for EKSO BIONICS HOLDINGS, INC.. The most recent filing was accepted on Mar 20, 2026.
Where does Trabud get CHRN insider trading data?
All CHRN insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.